Suppr超能文献

对接抑制剂的β淀粉样肽的分子动力学模拟分析

Molecular dynamics simulation analysis of the beta amyloid peptide with docked inhibitors.

作者信息

Aloufi Bandar, Alshammari Ahmad Mohajja, Alshammari Nawaf, Alam Mohammad Jahoor

机构信息

Department of Biology, College of Science, University of Hail, Kingdom of Saudi Arabia.

出版信息

Bioinformation. 2022 Jul 31;18(7):622-629. doi: 10.6026/97320630018622. eCollection 2022.

Abstract

Beta amyloid peptide is widely studied due to its association with Alzheimer disease (AD). Various study reported that the accumulation of beta amyloid in brain cells leads to Alzheimer disease. Hence, Beta amyloid peptide could be a potential target of anti-AD therapy. Hence, it is of interest to develop potent inhibitors for Beta amyloid peptide in the context of Alzheimer disease (AD). We report the binding features of Ascorbic acid, Cysteine, Dithioerythriol, Dithiothreitol, Malic acid and α-Tocopherol with beta amyloid having binding energy values of -6.7, -6.5, -6.0, -6.5, -6.7 and - 7.0 kcal/mol respectively. The molecular docking of top-scoring compounds with beta amyloid suggests that amino acids such as ASP23, GLU22, Phe19, are crucial in binding. Molecular dynamics simulation study showed steady-state interaction of compounds with beta amyloid for further consideration.

摘要

β淀粉样肽因其与阿尔茨海默病(AD)的关联而受到广泛研究。各种研究报告称,β淀粉样蛋白在脑细胞中的积累会导致阿尔茨海默病。因此,β淀粉样肽可能是抗AD治疗的潜在靶点。因此,在阿尔茨海默病(AD)的背景下开发针对β淀粉样肽的有效抑制剂具有重要意义。我们报告了抗坏血酸、半胱氨酸、二硫赤藓糖醇、二硫苏糖醇、苹果酸和α-生育酚与β淀粉样蛋白的结合特征,其结合能值分别为-6.7、-6.5、-6.0、-6.5、-6.7和-7.0 kcal/mol。得分最高的化合物与β淀粉样蛋白的分子对接表明,ASP23、GLU22、Phe19等氨基酸在结合中至关重要。分子动力学模拟研究表明,化合物与β淀粉样蛋白的稳态相互作用值得进一步研究。

相似文献

1
Molecular dynamics simulation analysis of the beta amyloid peptide with docked inhibitors.
Bioinformation. 2022 Jul 31;18(7):622-629. doi: 10.6026/97320630018622. eCollection 2022.

引用本文的文献

本文引用的文献

1
Alzheimer disease.
Nat Rev Dis Primers. 2021 May 13;7(1):33. doi: 10.1038/s41572-021-00269-y.
4
Control of apoptosis by SMAR1.
Mol Biosyst. 2017 Jan 31;13(2):350-362. doi: 10.1039/c6mb00525j.
6
β-Amyloid: the key peptide in the pathogenesis of Alzheimer's disease.
Front Pharmacol. 2015 Sep 30;6:221. doi: 10.3389/fphar.2015.00221. eCollection 2015.
7
pkCSM: Predicting Small-Molecule Pharmacokinetic and Toxicity Properties Using Graph-Based Signatures.
J Med Chem. 2015 May 14;58(9):4066-72. doi: 10.1021/acs.jmedchem.5b00104. Epub 2015 Apr 22.
8
The application of in silico drug-likeness predictions in pharmaceutical research.
Adv Drug Deliv Rev. 2015 Jun 23;86:2-10. doi: 10.1016/j.addr.2015.01.009. Epub 2015 Feb 7.
9
BACE1 inhibitor drugs in clinical trials for Alzheimer's disease.
Alzheimers Res Ther. 2014 Dec 24;6(9):89. doi: 10.1186/s13195-014-0089-7. eCollection 2014.
10
Do current therapeutic anti-Aβ antibodies for Alzheimer's disease engage the target?
Acta Neuropathol. 2014;127(6):803-10. doi: 10.1007/s00401-014-1290-2. Epub 2014 May 7.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验